Denali Therapeutics Inc.

Символ: DNLI

NASDAQ

20.86

USD

Пазарна цена днес

  • -19.5339

    Съотношение P/E

  • -0.2092

    Коефициент PEG

  • 2.88B

    MRK Cap

  • 0.00%

    Доходност на DIV

Denali Therapeutics Inc. Структура на управлението

Информация за управлението

ИмеЗаглавие
Mr. Joe Lewcock Ph.D.Chief Scientific Officer
Mr. Tyler M. NielsenSenior Vice President of Corporate Finance
Dr. Dana AndersenChief Technical and Manufacturing Officer
Dr. Ryan J. Watts Ph.D.Co-Founder, President, Chief Executive Officer & Director
Dr. Carole Ho M.D.Chief Medical Officer & Head of Development
Dr. Laura HansenVice President of Investor Relations
Dr. Marc Tessier-Lavigne Ph.D.Co-Founder & Independent Director
Mr. Chris WalshGeneral Counsel
Mr. Mark RowenVice President of Corporate Development
Dr. Alexander O. Schuth M.D.Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary